RVO

EDF Europadag 2026

15 Jan 2026 | Netherlands

HomeMarketplaceContact

InvestmentUpdated on 8 January 2026

Rebooting the immune system.

Founder / CEO at Reboot

Woerdense Verlaat, Netherlands

About

Our Hsp70-based treatment reverses immunoparalysis - a condition where the immune system shuts down after severe injury - without the limitations of current approaches that suppress T-cell function. With 30% of ICU deaths attributed to hospital-acquired infections in immune-compromised patients, we address a €2B+ market with no approved therapies. We are seeking seed funding to complete preclinical validation and secure European Defence Fund co-financing for military trauma applications. More info: rebootsciences.com

Organisation

Reboot

Start-up / scale-up

Woerdense Verlaat, Netherlands

Similar opportunities